BrightSpring Reports 29% Revenue Growth $3.15B Q2, Beats Estimates

BrightSpring Health Services, Inc. reported strong financial results for the second quarter of 2025, with revenues reaching approximately $3.15 billion, marking a year-over-year increase of about 29%. The company’s adjusted earnings per share of $0.22 surpassed analyst expectations, reflecting a 15.79% earnings surprise and improved profitability compared to the prior year. BrightSpring raised its full-year revenue guidance to around $12.4 billion and increased EBITDA guidance to $597.5 million, both figures exceeding market estimates. Operationally, the Pharmacy Solutions segment contributed the majority of revenue, while the company also expanded its specialty pharmacy services and maintained an extensive national presence across all 50 states, Puerto Rico, and Canada. CEO Jon Rousseau highlighted the company’s focus on quality care and operational excellence as key drivers of its strong performance, with long-term revenue growth outpacing the healthcare sector average. Free cash flow also improved significantly, indicating enhanced financial health and operational efficiency.